Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 12 Month, Multicenter, Randomized, Parallel, Open-label Study, to Evaluate Renal Function and Efficacy of Everolimus With Basiliximab and Cyclosporine Microemulsion Discontinuation at 3 Month Post-transplant Versus Minimization, in de Novo Kidney Transplant Recipients

NCT00154284 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT00154284
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00154284 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 12 Month, Multicenter, Randomized, Parallel, Open-label Study, to Evaluate Renal Function and Efficacy of Everolimus With Basiliximab and Cyclosporine Microemulsion Discontinuation at 3 Month Post-transplant Versus Minimization, in de Novo Kidney Transplant Recipients
Lead sponsor
Novartis
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2005
Completion date
July 31, 2008
Enrollment
114 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

organ transplantation, renal transplantation